Intra-ophthalmic Artery Chemotherapy for Retinoblastoma

Matthew W. Wilson; Brian Tse; Rachel C. Brennan

doi:10.1007/978-3-662-43451-2_12

Intra-ophthalmic Artery Chemotherapy for Retinoblastoma

Matthew W. Wilson, Brian Tse, Rachel C. Brennan

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today.

Original language	English (US)
Title of host publication	Clinical Ophthalmic Oncology: Retinoblastoma, Second Edition
Publisher	Springer Berlin Heidelberg
Pages	129-136
Number of pages	8
ISBN (Print)	9783662434512, 9783662434505
DOIs	https://doi.org/10.1007/978-3-662-43451-2_12
State	Published - Jan 1 2015
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Medicine(all)

Cite this

Wilson, M. W., Tse, B., & Brennan, R. C. (2015). Intra-ophthalmic Artery Chemotherapy for Retinoblastoma. In Clinical Ophthalmic Oncology: Retinoblastoma, Second Edition (pp. 129-136). Springer Berlin Heidelberg. https://doi.org/10.1007/978-3-662-43451-2_12

@inbook{a2a01b2722384c9cae4373ceae88e007,

title = "Intra-ophthalmic Artery Chemotherapy for Retinoblastoma",

abstract = "The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today.",

author = "Wilson, {Matthew W.} and Brian Tse and Brennan, {Rachel C.}",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-3-662-43451-2_12",

language = "English (US)",

isbn = "9783662434512",

pages = "129--136",

booktitle = "Clinical Ophthalmic Oncology: Retinoblastoma, Second Edition",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Intra-ophthalmic Artery Chemotherapy for Retinoblastoma

AU - Wilson, Matthew W.

AU - Tse, Brian

AU - Brennan, Rachel C.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today.

AB - The origin of intra-ophthalmic artery chemotherapy (SSIOAC) dates back to the 1950s. Cases of advanced intraocular retinoblastoma with (1) large multiple lesions still having enough normal retina so visual preservation was possible, (2) vitreous seeds, or (3) tumors refractory to other treatments presented a challenge for Reese and other early pioneers in the treatment of retinoblastoma, as they unfortunately still do today.

UR - http://www.scopus.com/inward/record.url?scp=84956712039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84956712039&partnerID=8YFLogxK

U2 - 10.1007/978-3-662-43451-2_12

DO - 10.1007/978-3-662-43451-2_12

M3 - Chapter

AN - SCOPUS:84956712039

SN - 9783662434512

SN - 9783662434505

SP - 129

EP - 136

BT - Clinical Ophthalmic Oncology: Retinoblastoma, Second Edition

PB - Springer Berlin Heidelberg

ER -

Access to Document

10.1007/978-3-662-43451-2_12